THE MOUSE EAR AS A MODEL FOR CUTANEOUS IRRITATION

REFERENCES

• Gábor M. Mouse Ear Inflammation Models and Their Pharmacological Applications. Akadémiai Kiadó, Budapest 2000
   Google Scholar
• Patrick E., Maibach H.I., Burkhalter A. Mechanisms of Chemically Induced Skin Irritation. I. Studies of Time Course, Dose Response, and Components of Inflammation in the Laboratory Mouse. Toxicol. Appl. Pharmacol. 1985; 81: 476–490
   PubMed Web of Science ®Google Scholar
• Patrick E., Burkhalter A., Maibach H.I. Recent Investigations of Mechanisms of Chemically Induced Skin Irritation in Laboratory Mice. J. Investig. Dermatol. 1987; 88: 24s–31s
   PubMed Web of Science ®Google Scholar
• Tonelli G., Thibault L., Ringler I. Bio-assay for the Concomitant Assessment of the Antiphlogistic and Thymolytic Activities of Topically Applied Corticoids. Endocrinology 1965; 77: 625–634
   PubMed Web of Science ®Google Scholar
• Van Arman C.G. Anti-inflammatory Drugs. Clin. Pharmacol. Ther. 1979; 16: 900–904
   Google Scholar
• De Bernardis E., Leonardi G., Caruso A., Cutuli V.M.C., Amico-Roxas M. Protective Effects of Papaverine Salicylate in Mouse Ear Dermatitis and PAF-Induced Rat Paw Oedema. Agents Actions 1994; 42: 29–33
   PubMedGoogle Scholar
• Towbin H., Pignat W., Wiesenberg I. Time-Dependent Cytokine Production in the Croton Oil-Induced Mouse Ear Oedema and Inhibition by Prednisolone. Inflamm. Res. 1995; 44(Suppl. 2)S160–S161
   PubMedGoogle Scholar
• Carlson R.P., O'Neill-Davis L., Chang J., Lewis A.J. Modulation of Mouse Ear Edema by Cyclooxygenase and Lipoxygenase Inhibitors and Other Pharmacologic Agents. Agents Actions 1985; 17: 197–204
   PubMedGoogle Scholar
• Fürstenberger G., Csuk-Glänzer B.I., Marks F., Keppler D. Phorbol Ester-Induced Leukotriene Biosynthesis and Tumor Promotion in Mouse Epidermis. Carcinogenesis 1994; 15: 2823–2827
   PubMed Web of Science ®Google Scholar
• Boris A., Hurley J.F. Assessment of Topical Anti-inflammatory Activity in Rats with Cantharidin-Induced Inflammation. J. Investig. Dermatol. 1977; 68: 161–164
   PubMed Web of Science ®Google Scholar
• Tarayre J.P., Aliaga M., Barbara M., Caillol V., Lauressergues H. Pharmacological Study of Cantharidin-Induced Ear Inflammation in Mice. J. Pharmacol. Methods 1984; 11: 271–277
   PubMedGoogle Scholar
• Tarayre J.P., Aliaga M., Barbara M., Tisné-Versailles J. Hypotheses on a Possible Role of Some Mediators in Various Inflammatory Reactions on Mouse Ear. Methods Find. Exp. Clin. Pharmacol. 1988; 10: 623–627
   PubMed Web of Science ®Google Scholar
• Inoue H., Asaka T., Nagata N., Koshihara Y. Mechanism of Mustard Oil-Induced Skin Inflammation in Mice. Eur. J. Pharmacol. 1997; 333: 231–240
   PubMed Web of Science ®Google Scholar
• Young J.M., Doreen A., Spires M.S., Bedord Ch.J., Wagner B., Ballaron S.J., De Young L.M. The Mouse Ear Inflammatory Response to Topical Arachidonic Acid. J. Investig. Dermatol. 1984; 82: 367–371
   PubMed Web of Science ®Google Scholar
• Young J.M., Wagner B.M., Spires D.A. Tachyphylaxis in 12-O-Tetradecanoylphorbol Acetate-and Arachidonic Acid-Induced Ear Edema. J. Investig. Dermatol. 1983; 80: 48–52
   PubMed Web of Science ®Google Scholar
• Chang J., Carlson R.P., O'Neill-Davis L., Lamb B., Sharma R.N., Lewis A.J. Correlation Between Mouse Skin Inflammation Induced by Arachidonic Acid and Eicosanoid Synthesis. Inflammation 1986; 10: 205–214
   PubMed Web of Science ®Google Scholar
• Inoue H., Mori T., Koshihara Y. Sulfidopeptide-Leukotrienes Are Major Mediators of Arachidonic Acid-Induced Mouse Ear Oedema. Prostaglandins 1988; 36: 73l–739
   Google Scholar
• Young J.M., De Young L.M. Cutaneous Models of Inflammation for the Evaluation of Topical and Systemic Pharmacological Agents. Pharmacological Methods in the Control of Inflammation, J.Y. Chang, A.J. Lewis. Alan R. Liss, Inc., New York 1989; 215–231
   Google Scholar
• Kotyuk B., Raychaudhury A., DiPasquale G. Effect of Anti-inflammatory Compounds on Oedema Formation and Myeloperoxidase Activity in the Arachidonic Acid-Induced Ear Model in the Mouse. Agents Actions 1993; 39: C46–C48, Spec. Conf. Issue
   PubMedGoogle Scholar
• Müller K. Antipsoriatic and Proinflammatory Action of Anthralin. Implications for the Role of Oxygen Radicals. Biochem. Pharmacol. 1997; 53: 1215–1221
   PubMed Web of Science ®Google Scholar
• Kemény L., Csató M., Dobozy A. Pharmacological Studies on Dithranol-Induced Irritative Dermatitis in Mice. Dermatol. Res. 1989; 281: 362–365
   PubMed Web of Science ®Google Scholar
• Wiegrebe W., Müller K. Treatment of Psoriasis with Anthrones—Chemical Principles, Biochemical Aspects, and Approaches to the Design of Novel Derivatives. Skin Pharmacol. 1995; 8: 1–24
   PubMedGoogle Scholar
• Jancsó M. Speicherung. Stoffanreicherung in Retikuloendothel und in der Niere. Akadémiai Kiadó, Budapest 1955
   Google Scholar
• Jancsó M. Inflammation and the Inflammatory Mechanisms. (Review Article). J. Pharm. Pharmacol. 1961; 13: 577–594
   PubMed Web of Science ®Google Scholar
• Jancsó N. Role of the Nerve Terminals in the Mechanism of Inflammatory Reactions. Bull. Millard Fillmore Hosp. (Buffalo, NY) 1960; 7: 53–77
   Google Scholar
• Gábor M., Rázga Zs. Influence of Nonsteroidal Antiphlogistics on Mouse Ear Inflammation Induced with Croton Oil. Arch. Int. Pharmacodyn. 1989; 299: 241–246
   PubMedGoogle Scholar
• Gábor M., Rázga Zs. Effects of Non-steroidal Antiphlogistics on Mouse Ear Oedema Induced with Dithranol. Acta Physiol. Acad. Sci. Hung. 1990; 75: 287–291
   Google Scholar
• Gábor M., Rázga Zs. Development and Inhibition of Mouse Ear Oedema Induced with Capsaicin. Agents Actions 1992; 36: 83–86
   PubMedGoogle Scholar
• Inoue H., Nagata N., Koshihara Y. Profile of Capsaicin-Induced Mouse Ear Oedema as Neurogenic Inflammatory Model: Comparison with Arachidonic Acid-Induced Ear Oedema. Br. J. Pharmacol. 1993; 110: 1614–1620
   PubMed Web of Science ®Google Scholar
• Inoue H., Nagata N., Koshihara Y. Involvement of Substance P as a Mediator in Capsaicin-Induced Mouse Ear Oedema. Inflamm. Res. 1995a; 44: 470–474
   PubMed Web of Science ®Google Scholar
• Inoue H., Nagata N., Koshihara Y. Participation of Serotonin in Capsaicin-Induced Mouse Ear Oedema. Jpn. J. Pharmacol. 1995b; 69: 61–68
   PubMedGoogle Scholar
• Brattsand R., Thalen A., Roempke K., Källström L., Gruvstad E. Influence of 16α,17α-Acetal Substitution and Steroid Nucleus Fluorination on the Topical to Systemic Activity Ratio of Glucocorticoids. J. Steroid Biochem. 1982; l6: 779–786
   Google Scholar
• Maloff B.L., Shaw J.E., Di Meo T.M. IL-1 Dependent Model of Inflammation Mediated by Neutrophils. J. Pharmacol. Methods 1989a; 22: 133–140
   PubMedGoogle Scholar
• Maloff B.L., Shaw J.E., Di Meo T.M., Fox D., Bruin E.M. Development of a RIA-Based Primary Screen for IL-1 Antagonists. Clin. Chim. Acta 1989b; 180: 73–78
   PubMed Web of Science ®Google Scholar
• Van Arman C.G., Begany A.J., Miller L.M., Pless H.H. Some Details of the Inflammations Caused by Yeast and Carrageenin. J. Pharm. Exp. Ther. 1965; 150: 328–334
   Web of Science ®Google Scholar
• Gadó K., Gigler G. Zymosan Inflammation: A New Method Suitable for Evaluating New Antiinflammatory Drugs. Agents Actions 1991; 32: 119–121
   PubMedGoogle Scholar
• Williams T.J., Jose P.J. Mediation of Increased Vascular Permeability After Complement Activation. J. Exp. Med. 1981; 153: 136–153
   PubMed Web of Science ®Google Scholar
• Eisenberg S.P., Evans R.J., Arend W.P., Verderber E., Brewer M.T., Hannum C.H., Thompson R.C. Primary Structure and Functional Expression from Complementary DNA of a Human Interleukin-1 Receptor Antagonist. Nature 1990; 343: 341–346
   PubMed Web of Science ®Google Scholar
• Roberge C.J., Grassi J., De Médicis R., Frobert Y., Lussier A., Nakkache P.H., Poubelle P.E. Crystal–Neutrophil Interactions Lead to Interleukin-1 Synthesis. Agents Actions 1991; 34: 38–41
   PubMedGoogle Scholar
• Erdó F., Török K., Arányi P., Székely J.I. A New Assay for Antiphlogistic Activity: Zymosan-Induced Mouse Ear Inflammation. Agents Actions 1993; 39: 137–142
   PubMedGoogle Scholar
• Erdó F., Török K., Arányi P., Székely J.I. Zymosan Induced Mouse Ear Edema: A New Animal Model of Inflammation. Pharmacol. Res. 1992; 25(Suppl. 2)236–237
   Google Scholar
• Tsuji F., Miyake Y., Enomoto H., Horiuchi M., Mita S. Effects of SA 6541, a Leukotriene A4 Hydrolase Inhibitor, and Indomethacin on Carrageenan-Induced Murine Dermatitis. Eur. J. Pharmacol. 1998a; 346: 81–85
   PubMed Web of Science ®Google Scholar
• Tsuji F., Miyake Y., Horiuchi M., Mita S. Involvement of Leukotriene B4 in Murine Dermatitis Models. Biochem. Pharmacol. 1998b; 55: 297–304
   PubMed Web of Science ®Google Scholar